论文部分内容阅读
多发性硬化症是一种脱髓鞘性疾病,病因至今还不十分清楚。但不少学者认为,它是一种与病毒感染有关的自身免疫性疾病。以往,常用促肾上腺皮质激素(ACTH)治疗,但效果不佳,只能缩短急性发作期的时间。最近,美国的研究者经过临床试验,发现了两种治疗多发性硬化症有效的新疗法。他们已把研究结果发表在1983年第1期《新英格兰医学杂志》上。哈佛医学院韦纳等人,对58例多发性硬化症病人进行化疗试验,并把他们分成三组。第一组20例,单独用ACTH25单位每天静脉注射或肌肉注射,连续21天。第二组20
Multiple sclerosis is a demyelinating disease, and the etiology is still not fully understood. However, many scholars believe that it is an autoimmune disease associated with viral infection. In the past, adrenocorticotropic hormone (ACTH) treatment was commonly used, but the effect was poor and only the acute attack period was shortened. Recently, US researchers have conducted clinical trials and found two new treatments that are effective in treating multiple sclerosis. They have published their results in the first issue of the New England Journal of Medicine in 1983. Harvard Medical School Weiner et al. performed chemotherapy tests on 58 patients with multiple sclerosis and divided them into three groups. In the first group of 20 patients, ACTH25 units were administered intravenously or intramuscularly for 21 consecutive days. The second group 20